Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double Blind, Controlled Phase II Trial of the Safety, Tolerability and Immunogenicity of Fluzone® Inactivated Trivalent Influenza Virus Vaccine Administered With and Without JVRS-100 Adjuvant in Subjects 65 Years and Older

NCT00936468 is registered in ClinicalTrials.gov with Colby Pharmaceutical Company as lead sponsor.

NCT NCT00936468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00936468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double Blind, Controlled Phase II Trial of the Safety, Tolerability and Immunogenicity of Fluzone® Inactivated Trivalent Influenza Virus Vaccine Administered With and Without JVRS-100 Adjuvant in Subjects 65 Years and Older
Lead sponsor
Colby Pharmaceutical Company
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2009
Completion date
September 30, 2010
Enrollment
472 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

influenza